Supplementary Table S2 from TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics
Year: 2023
Type: supplementary-materials
Abstract: Multivariate analysis of factors affecting treatment outcomes in 106 patients with TP53 molecular alterations versus 82 patient with TP53 wild-type, by individual factors of MDACC score vs MDACC score (only factors with p value< 0.02 in univariate were included in multivariate analysis)*
Authors: Jennifer J. Wheler, Filip Janku, Aung Naing, Yali Li, Bettzy Stephen, Ralph Zinner, Vivek Subbiah, Siqing Fu, Daniel Karp, Gerald S. Falchook, Apostolia M. Tsimberidou, Sarina Piha-Paul, Roosevelt Anderson, Danxia Ke, Vincent Miller, Roman Yelensky, J. Jack Lee, David Hong, Razelle Kurzrock
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362484717